FDA approves Alembic Pharmaceuticals Aleor Dermaceuticals Nystatin Triamcinolone Acetonide Ointment
The authorised ANDA, Nystatin and Triamcinolone Acetonide Ointment is used to treat cutaneous candidiasis; studies have indicated that the nystatin-steroid combination is more effective in the first few days of therapy than the nystatin component alone. Alembic Pharmaceuticals Limited confirmed that its joint venture Aleor Dermaceuticals Limited has gained the final FDA clearance for its Abbreviated New Drug Application (ANDA) for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/gram. The authorised ANDA, Nystatin and Triamcinolone Acetonide Ointment is used to treat cutaneous candidiasis; studies have indicated that the nystatin-steroid combination is more effective in the first few days of therapy than the nystatin component alone.
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
